App-Quantinova.ai

Hemodialysis Access Thrombotic Events in Patients With Dialysis-Dependent CKD Randomized to Vadadustat vs Darbepoetin Alfa

Wolfgang Winkelmayer - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Darbepoetin alfa

Acute Kidney Injury due to Small for Size Syndrome after Liver Transplantation

swetha reddy - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

N/A

Renal Thrombotic Microangiopathy (TMA) without thrombocytopenia in patient with a multisystem hyperinflammatory state after Ad26.COV2.S COVID vaccine

Lei Win - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Venous thrombosis

Methylprednisolone

A unique case of suspected renal nutcracker syndrome in a patient with horseshoe kidney.

Paul Merchant - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Clopidogrel bisulfate

Catheter Directed Thrombolysis (CDT) of an Axillary Artery to Femoral Vein AV Graft

Athip Vatanapradith - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Fibrinogen (IV)

A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma potential in current real-world practice.

Kazufumi Kobayashi - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Atezolizumab

Malignant portal vein tumor thrombosis (PVTT) in patients with hepatocellular (HCC) carcinoma: Insights from a Western single-institutional cohort.

Sindhu Vikash - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Comparison of liver-directed combined radiotherapy versus sorafenib in patients with locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: An Asian Liver Radiotherapy Group Study.

Jinsil Seong - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Sorafenib

An open-label, multi-center phase IIIb study of durvalumab and tremelimumab as first-line treatment in patients with unresectable hepatocellular carcinoma (TREMENDOUS study).

Jia Fan - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Ticilimumab

Incidence and clinical characteristics of patients with LAPC and mesenteric vein thrombosis and current treatment paradigm.

Amer H. Zureikat - American Society of Clinical Oncology Gastrointestinal (ASCO GI) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Gemcitabine

Clinical characteristics, tumor genomic and transcriptomic profiles of patients (pts) with metastatic renal cell carcinoma (mRCC) who developed venous thromboembolism (VTE).

Haoran Li - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Comparison of postpartum anti-xa levels following enoxaparin administration to prevent venous thromboembolism using two protocols

Rozan Haj - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Enoxaparin

Venous thromboembolism in pregnancy and postpartum among women with physical disabilities

Marina Vainder - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Postpartum venous thromboembolism chemical prophylaxis and bleeding complications in a U.S. cohort

Ann M. Bruno - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Wild type through Omicron: Maternal outcomes across COVID-19 waves

Bijal Parikh - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Periviable birth and adverse maternal outcomes stratified by mode of delivery

Sarah Nazeer - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Periviable Births: Association of maternal morbidity with indications for delivery

Sarah Nazeer - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Trends in and outcomes associated with systemic lupus erythematosus and anti-phospholipid syndrome during U.S. deliveries

Ashley Lopez - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Severe morbidity for placenta accreta spectrum has decreased over time in referral centers

Brett D. Einerson - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Adverse outcomes and postpartum readmissions following peripartum hysterectomy among placenta accreta spectrum subtypes

Eve Overton - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts